In this featured publication, investigators review recent results of treatments for pediatric low-grade gliomas, including standard chemotherapy, therapies targeting the mitogen-activated protein kinase (MAPK) pathway, and proton-beam radiation therapy.
Bill Tiller, CEO of The Pediatric Brain Tumor Foundation (PBTF), Kimberly Roy-Canning, PBTF Northeast Regional Director, and John D’Ambrosio, PBTF Northeast Regional Campaign Manager came for a visit to DFCI on Tuesday, April 9, 2019. It was a lovely evening of presentations by the Dana-Farber PLGA program scientists, tours of the Jimmy Fund Clinic and […]
